Sign In
Buy VRTX
$441.74
+13.40 (+3.13%)
At Close: Jun 04, 2026
GSK vs. VRTX: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 05'th Mar 2024
Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with GSK (GSK) and Vertex Pharmaceuticals (VRTX). But which of these two stocks presents investors with the better
3 Biopharma Stocks You Don't Want to Miss in the New Bull Market
09:30am, Tuesday, 05'th Mar 2024
Vertex Pharmaceuticals is angling to treat acute pain with its new drug. Compass Pathways will have a major data update sometime in Q4.
Game Changers: 3 Biotech Stocks That Could Be Multibaggers in the Making
06:28am, Tuesday, 05'th Mar 2024
The world of biotech stocks offers a unique blend of high risk and potentially high reward. Companies operating in this space are constantly pushing the boundaries, making them primed investment oppor
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
04:09pm, Monday, 04'th Mar 2024
If you're looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ: IBB ) is an excellent place to start. It tracks the performance of the ICE Biotechnology Index, a collection of U.S.
ChatGPT Stock Predictions: 3 Biotech Companies the AI Bot Thinks Have 10X Potential
11:02am, Monday, 04'th Mar 2024
ChatGPT stock predictions could be more than shots in the dark by AI. The processing and inferential power of artificial intelligence progresses seemingly exponentially every day.
3 Magnificent Growth Stocks to Buy in March
09:30am, Saturday, 02'nd Mar 2024
Eli Lilly could have the world's future best-selling drug in its lineup. Moderna is poised to expand beyond COVID with several new products potentially on the way.
These 4 Stocks Are the "Magnificent Seven" of Healthcare
01:59am, Friday, 01'st Mar 2024
The Magnificent Seven are stealing the show this year on the market. They're all technology companies -- but there are opportunities elsewhere, too.
3 Biotech Stocks Bound to Blast Off By 2029
12:00pm, Tuesday, 27'th Feb 2024
Biotech stocks have long been a speculative, albeit rewarding way to invest in the advancement of medical technology. This industry has a wide range of companies, from start-up firms that are research
3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow
05:03am, Tuesday, 27'th Feb 2024
Vertex is a leader in the billion-dollar cystic fibrosis treatment market. The company recently expanded beyond this specialty area with a newly approved blood disorder therapy.
The Ultimate Growth Stock to Buy With $1,000 Right Now
05:52am, Monday, 26'th Feb 2024
Vertex Pharmaceuticals' positives include strong profitability and multiple growth drivers. The stock doesn't have the negatives of nosebleed valuation, intense competition, or super-high risk.
3 Secret Stocks to Double Your Money by 2028
03:02pm, Thursday, 22'nd Feb 2024
Uncovering the illusive secrets with stocks to double your money is an endeavor that captures the imagination of many. But the quest for lucrative opportunities becomes increasingly challenging with t
Vertex Pharmaceuticals Is About to Extend Its Leadership in This Billion-Dollar Market
05:35am, Tuesday, 20'th Feb 2024
Vertex brought in more than $9.8 billion last year thanks to its flagship cystic fibrosis drugs. The company is moving closer to the finish line with a new cystic fibrosis treatment that may even beat
3 Revolutionary Biotech Stocks Poised for 10X Surge
12:24pm, Monday, 19'th Feb 2024
Investing in high-potential biotech stocks should catapult your portfolio to new heights. Picture this: a global biotech market valued at a whopping $1.55 trillion in 2023 is set to catapult to $3.08
Could This News Upset Vertex Pharmaceuticals' Prospects in the Billion-Dollar Pain Management Market?
09:10am, Sunday, 18'th Feb 2024
Vertex plans on submitting its pain candidate to regulators by mid-year. A young biotech company just announced it's working on a very similar pain candidate.
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move.
02:25pm, Saturday, 17'th Feb 2024
Vertex Pharmaceuticals will soon try to commercialize another medicine. The new therapy targets the same market as four of its other products.
